You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

CLINICAL TRIALS PROFILE FOR CARTEOLOL HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for CARTEOLOL HYDROCHLORIDE

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02105285 ↗	Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension	Completed	Otsuka Pharmaceutical Co., Ltd.	Phase 3	2014-04-01	The purpose of this study is to determine the efficacy and safety of OPC-1085EL ophthalmic solution in comparison with carteolol long-acting ophthalmic solution in subjects who are insufficiently responsive to carteolol long-acting ophthalmic solution.
NCT02108288 ↗	Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers	Completed	Otsuka Pharmaceutical Co., Ltd.	Phase 1	2014-04-01	OPC-1085EL ophthalmic solution, carteolol long-acting ophthalmic solution or latanoprost ophthalmic solution are administered once daily for 7 days and the effect on the blood concentration of carteolol and latanoprost in OPC-1085EL ophthalmic solution by formulating the combination drug will be determined.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for CARTEOLOL HYDROCHLORIDE

Condition Name

Chart
Table

Condition Name for CARTEOLOL HYDROCHLORIDE
Intervention	Trials
Glaucoma	2
Ocular Hypertension	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for CARTEOLOL HYDROCHLORIDE
Intervention	Trials
Ocular Hypertension	2
Hypertension	1
Glaucoma	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for CARTEOLOL HYDROCHLORIDE

Trials by Country

Map
Table

Trials by Country for CARTEOLOL HYDROCHLORIDE
Location	Trials
Japan	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for CARTEOLOL HYDROCHLORIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for CARTEOLOL HYDROCHLORIDE
Clinical Trial Phase	Trials
Phase 3	1
Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for CARTEOLOL HYDROCHLORIDE
Clinical Trial Phase	Trials
Completed	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CARTEOLOL HYDROCHLORIDE

Sponsor Name

Chart
Table

Sponsor Name for CARTEOLOL HYDROCHLORIDE
Sponsor	Trials
Otsuka Pharmaceutical Co., Ltd.	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for CARTEOLOL HYDROCHLORIDE
Sponsor	Trials
Industry	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.